In the hospitals and clinics of eastern China, a fourteen-year reckoning has arrived: the antiretroviral drugs that once represented progress in the fight against HIV have, through decades of widespread use, taught the virus how to survive them. Researchers at Huzhou Central Hospital have documented drug resistance rates more than double the threshold the World Health Organization considers a public health emergency, while a newer generation of treatments achieves what the old ones cannot. The story is one medicine has told before — that solutions, left unchanged long enough, can become part o
China's HIV drug resistance surges as older antiretrovirals lose efficacy
Treatment failures in HIV patients using older regimens resulted in sustained viral replication and continued disease progression, with implications for transmission and mortality risk.